OpenLB
Open Library of Bioscience

Brevilin A inhibits RANKL-induced osteoclast differentiation and bone resorption.

Abstract

Keywords

References

1. An J, Yang H, Zhang Q, Liu C, Zhao J, Zhang L, Chen B (2016) Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblast-mediated bone formation. Life Sci 147:46–58 [DOI: 10.1016/j.lfs.2016.01.024]
2. Burgers T, Vivanco J, Zahatnansky J, Moren A, Mason J, Williams B (2016) Mice with a heterozygous Lrp6 deletion have impaired fracture healing. Bone Res 4:16025 [DOI: 10.1038/boneres.2016.25]
3. Chan C, Xie X, Wan S, Zhou G, Yuen A, Mok D, Chen S (2019) Qualitative and quantitative analysis of sesquiterpene lactones in Centipeda minima by UPLC-Orbitrap-MS & UPLC-QQQ-MS. J Pharm Biomed Anal 174:360–366 [DOI: 10.1016/j.jpba.2019.05.067]
4. Chen X, Du Y, Nan J, Zhang X, Qin X, Wang Y, Hou J, Wang Q, Yang J (2013) Brevilin A, a novel natural product, inhibits janus kinase activity and blocks STAT3 signaling in cancer cells. PLoS ONE 8(5):e63697 [DOI: 10.1371/journal.pone.0063697]
5. Cheng Y, Huang L, Wang Y, Huo Q, Shao Y, Bao H, Li Z, Liu Y, Li X (2019) Strontium promotes osteogenic differentiation by activating autophagy via the the AMPK/mTOR signaling pathway in MC3T3-E1 cells. Int J Mol Med 44(2):652–660 [PMID: 31173178]
6. Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen JB, McClung M, Roux C, Törring O, Valter I, Wang AT, Brown JP (2018) Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res 33(2):190–198 [DOI: 10.1002/jbmr.3337]
7. Devi S, Ansari SA, Tenguria S, Kumar N, Ahmed N (2016) Multipronged regulatory functions of a novel endonuclease (TieA) from Helicobacter pylori. Nucleic Acids Res 44(19):9393–9412 [PMID: 27550181]
8. Gohda J, Akiyama T, Koga T, Takayanagi H, Tanaka S, Inoue J (2005) RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis. Embo J 24(4):790–799 [DOI: 10.1038/sj.emboj.7600564]
9. Gong W, Liu M, Zhang Q, Zhang Q, Wang Y, Zhao Q, Xiang L, Zheng C, Zhang Q, Qin L (2022) Orcinol glucoside improves senile osteoporosis through attenuating oxidative stress and autophagy of osteoclast via activating Nrf2/Keap1 and mTOR signaling pathway. Oxid Med Cell Longev 2022:5410377 [DOI: 10.1155/2022/5410377]
10. Hattner R, Epker B, Frost H (1965) Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling. Nature 206(983):489–490 [DOI: 10.1038/206489a0]
11. Hsu YH, Chen WY, Chan CH, Wu CH, Sun ZJ, Chang MS (2011) Anti-IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss. J Exp Med 208(9):1849–1861 [DOI: 10.1084/jem.20102234]
12. Ichikawa H, Nair M, Takada Y, Sheeja D, Kumar M, Oommen O, Aggarwal B (2006) Isodeoxyelephantopin, a novel sesquiterpene lactone, potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis through suppression of nuclear factor-kappaB (nf-kappaB) activation and nf-kappaB-regulated gene expression. Clin Cancer Res 12(19):5910–5918 [DOI: 10.1158/1078-0432.CCR-06-0916]
13. Jeong E, Choi HK, Park JH, Lee SY (2018) STAC2 negatively regulates osteoclast formation by targeting the RANK signaling complex. Cell Death Differ 25(8):1364–1374 [DOI: 10.1038/s41418-017-0048-5]
14. Jiang C, Wang Y, Zhang M, Xu J (2022) Cholesterol inhibits autophagy in RANKL-induced osteoclast differentiation through activating the PI3K/AKT/mTOR signaling pathway. Mol Biol Rep 49(10):9217–9229 [DOI: 10.1007/s11033-022-07747-w]
15. Kerkman JN, Daffertshofer A, Gollo LL, Breakspear M, Boonstra TW (2018) Network structure of the human musculoskeletal system shapes neural interactions on multiple time scales. Sci Adv 4(6):eaat0497 [DOI: 10.1126/sciadv.aat0497]
16. Khan M, Maryam A, Saleem M, Shakir H, Qazi J, Li Y, Ma T (2020) Brevilin A induces ROS-dependent apoptosis and suppresses STAT3 activation by direct binding in human lung cancer cells. J Cancer 11(13):3725–3735 [DOI: 10.7150/jca.40983]
17. Khosla S, Hofbauer LC (2017) Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol 5(11):898–907 [DOI: 10.1016/S2213-8587(17)30188-2]
18. Kim SS, Jeong SP, Park BS, Kim IR (2022) Melatonin attenuates RANKL-induced osteoclastogenesis via inhibition of Atp6v0d2 and DC-STAMP through MAPK and NFATc1 signaling pathways. Molecules 27(2):501. https://doi.org/10.3390/molecules27020501
19. Kobza A, Papaioannou A, Lau A, Adachi J (2020) Romosozumab in the treatment of osteoporosis. Immunotherapy 12(13):965–981 [DOI: 10.2217/imt-2020-0158]
20. Lee D, Kwak HJ, Kim BH, Kim DW, Kim HY, Kim SH, Kang KS (2022) Brevilin a isolated from Centipeda minima Induces Apoptosis in human gastric cancer cells via an extrinsic apoptotic signaling pathway. Plants (Basel) 11(13):1658. https://doi.org/10.3390/plants11131658 [DOI: 10.3390/plants11131658]
21. Lee M, Chan B, Wong W, Leung T, Qu Z, Huang J, Zhu L, Lee C, Chen S, Tai W (2020) Synthesis and evaluation of novel anticancer compounds derived from the natural product brevilin A. ACS Omega 5(24):14586–14596 [DOI: 10.1021/acsomega.0c01276]
22. Lee S, Park K, Yu H, Kook E, Song W, Lee G, Koh J, Shin H, Choi J, Huh Y, Ryu J (2019) Controlling hypoxia-inducible factor-2α is critical for maintaining bone homeostasis in mice. Bone Res 7:14 [DOI: 10.1038/s41413-019-0054-y]
23. Li J, Jiang M, Yu Z, Xiong C, Pan J, Cai Z, Xu N, Zhou X, Huang Y, Yang Z (2022) Artemisinin relieves osteoarthritis by activating mitochondrial autophagy through reducing TNFSF11 expression and inhibiting PI3K/AKT/mTOR signaling in cartilage. Cell Mol Biol Lett 27(1):62 [DOI: 10.1186/s11658-022-00365-1]
24. Liu L, Chen X, Jiang Y, Yuan Y, Yang L, Hu Q, Tang J, Meng X, Xie C, Shen X (2022) viaBrevilin A ameliorates acute lung injury and inflammation through inhibition of NF-κB signaling targeting IKKα/β. Front Pharmacol 13:911157 [DOI: 10.3389/fphar.2022.911157]
25. Liu R, Qu Z, Lin Y, Lee C, Tai W, Chen S (2019) Brevilin A induces cell cycle arrest and apoptosis in nasopharyngeal carcinoma. Front Pharmacol 10:594 [DOI: 10.3389/fphar.2019.00594]
26. Liu Y, Zhou G (2022) Promising anticancer activities and mechanisms of action of active compounds from the medicinal herb Centipeda minima (L.) A Braun & Asch. Phytomedicine 106:154397 [DOI: 10.1016/j.phymed.2022.154397]
27. Matsushita T, Chan Y, Kawanami A, Balmes G, Landreth G, Murakami S (2009) Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis. Mol Cell Biol 29(21):5843–5857 [DOI: 10.1128/MCB.01549-08]
28. Miyamoto T, Arai F, Ohneda O, Takagi K, Anderson D, Suda T (2000) An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. Blood 96(13):4335–4343 [DOI: 10.1182/blood.V96.13.4335]
29. Miyauchi Y, Ninomiya K, Miyamoto H, Sakamoto A, Iwasaki R, Hoshi H, Miyamoto K, Hao W, Yoshida S, Morioka H, Chiba K, Kato S, Tokuhisa T, Saitou M, Toyama Y, Suda T, Miyamoto T (2010) The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. J Exp Med 207(4):751–762 [DOI: 10.1084/jem.20091957]
30. Pazouki L, Memari HR, Kännaste A, Bichele R, Niinemets Ü (2015) Germacrene A synthase in yarrow (Achillea millefolium) is an enzyme with mixed substrate specificity: gene cloning, functional characterization and expression analysis. Front Plant Sci 6:111 [DOI: 10.3389/fpls.2015.00111]
31. Qin Q, Xu G, Zhan X, Wang Z, Wang Y, Liu H, Hou X, Shi W, Ma J, Bai Z, Xiao X (2021) Brevilin A inhibits NLRP3 inflammasome activation in vivo and in vitro by acting on the upstream of NLRP3-induced ASC oligomerization. Mol Immunol 135:116–126 [DOI: 10.1016/j.molimm.2021.03.025]
32. Qu Z, Lin Y, Mok DK, Bian Q, Tai WC, Chen S (2020) Brevilin A, a Natural sesquiterpene lactone inhibited the growth of triple-negative breast cancer cells via Akt/mTOR and STAT3 signaling pathways. Onco Targets Ther 13:5363–5373 [DOI: 10.2147/OTT.S256833]
33. Saleem M, Nisar M, Alshwmi M, Din S, Gamallat Y, Khan M, Ma T (2020) Brevilin A inhibits STAT3 signaling and induces ROS-dependent apoptosis, mitochondrial stress and endoplasmic reticulum stress in MCF-7 breast cancer cells. Onco Targets Ther 13:435–450 [DOI: 10.2147/OTT.S228702]
34. Su T, Wang Y, Wang X, Li C, Zhu P, Huang Y, Yang Z, Chen S, Yu Z (2020) The JAK2/STAT3 pathway is involved in the anti-melanoma effects of brevilin A. Life Sci 241:117169 [DOI: 10.1016/j.lfs.2019.117169]
35. Sun W, Yang G, Zhang F, Feng C, Liang M, Jia P, Zhao Z, Guo H, Zhao Y (2022) Artemisia annuaEffects of L. Essential oil on osteoclast differentiation and function induced by RANKL. Evid-Based Complement Alternat Med 2022:1322957 [PMID: 35432559]
36. Tong X, Gu J, Song R, Wang D, Sun Z, Sui C, Zhang C, Liu X, Bian J, Liu Z (2019) Osteoprotegerin inhibit osteoclast differentiation and bone resorption by enhancing autophagy via AMPK/mTOR/p70S6K signaling pathway in vitro. J Cell Biochem. 120(2):1630–1642. https://doi.org/10.1002/jcb.27468 [DOI: 10.1002/jcb.27468]
37. Wang J, Li M, Cui X, Lv D, Jin L, Khan M, Ma T (2018) Brevilin A promotes oxidative stress and induces mitochondrial apoptosis in U87 glioblastoma cells. Onco Targets Ther 11:7031–7040 [DOI: 10.2147/OTT.S179730]
38. Wu C, Su Z, Lin M, Ou J, Zhao W, Cui J, Wang RF (2017) NLRP11 attenuates Toll-like receptor signalling by targeting TRAF6 for degradation via the ubiquitin ligase RNF19A. Nat Commun 8(1):1977 [DOI: 10.1038/s41467-017-02073-3]
39. Xie G, Liu W, Lian Z, Xie D, Yuan G, Ye J, Lin Z, Wang W, Zeng J, Shen H, Wang X, Feng H, Cong W, Yao G (2021) Spleen tyrosine kinase (SYK) inhibitor PRT062607 protects against ovariectomy-induced bone loss and breast cancer-induced bone destruction. Biochem Pharmacol 188:114579 [DOI: 10.1016/j.bcp.2021.114579]
40. You P, Wu H, Deng M, Peng J, Li F, Yang Y (2018) Brevilin A induces apoptosis and autophagy of colon adenocarcinoma cell CT26 via mitochondrial pathway and PI3K/AKT/mTOR inactivation. Biomed Pharmacother = Biomed Pharmacother 98:619–625 [DOI: 10.1016/j.biopha.2017.12.057]
41. Yu W, Zhong L, Yao L, Wei Y, Gui T, Li Z, Kim H, Holdreith N, Jiang X, Tong W, Dyment N, Liu XS, Yang S, Choi Y, Ahn J, Qin L (2021) Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss. J Clin Invest. 131(2):e140214. https://doi.org/10.1172/JCI140214 [DOI: 10.1172/JCI140214]
42. Zhang X, Xia Y, Yang L, He J, Li Y, Xia C (2019) Brevilin A, a sesquiterpene lactone, inhibits the replication of influenza a virus in vitro and in vivo. Viruses 11(9):835. https://doi.org/10.3390/v11090835 [DOI: 10.3390/v11090835]
43. Zhu G, Chen W, Tang C, McVicar A, Edwards D, Wang J, McConnell M, Yang S, Li Y, Chang Z, Li Y (2022) Knockout and double knockout of cathepsin K and Mmp9 reveals a novel function of cathepsin K as a regulator of osteoclast gene expression and bone homeostasis. Int J Biol Sci 18(14):5522–5538 [DOI: 10.7150/ijbs.72211]
44. Zhu L, Tang Y, Li XY, Keller ET, Yang J, Cho JS, Feinberg TY, Weiss SJ (2020) Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases. Sci Transl Med 12(529):eaaw6143. https://doi.org/10.1126/scitranslmed.aaw6143 [DOI: 10.1126/scitranslmed.aaw6143]

Grants

1. 82103652/National Natural Science Foundation of China
2. 220506096490299/Shantou Science and Technology Project
3. 190606175268442/Shantou Science and Technology Project
4. 20232084/Traditional Chinese Medicine Bureau of Guangdong Province

MeSH Term

Chemicals